SPY468.01-0.27 -0.06%
DIA356.89-0.85 -0.24%
IXIC15,725.50+38.58 0.25%

--Raymond James Adjusts Price Target on Cymabay Therapeutics to $14 from $12, Keeps Strong Buy Rating

MT Newswires · 11/11/2021 07:23

Please log in to view news